Apple stock falls as foldable iPhone delay and China patent ruling

Apple’s shares dropped more than 4% in Tuesday trading, not because of weak earnings but due to worries about future growth prospects [1]. The market reacted to reports of engineering challenges delaying Apple’s first foldable iPhone and to a Chinese court ruling upholding rival AI patents that could increase Apple’s licensing costs [1].

Key takeaways

• Apple posted record iPhone revenue of $85.27 billion and total revenue of $143.76 billion, beating earnings expectations [1].
• A delay in the foldable iPhone, expected to represent less than 10% of this year’s lineup, is attributed to engineering hurdles rather than supplier issues [1].
• China’s Supreme People’s Court upheld AI patents held by Xiao‑I Corp, a setback that may raise Apple’s future licensing expenses in a key growth market [1].
• Analysts remain largely neutral to bullish, with UBS maintaining a $280 price target and Bank of America keeping a Buy rating with a $320 target [1].
• Apple’s market capitalization stands at about $4.5 trillion, making it the world’s third‑largest company by market value [3].

Engineering hurdles and legal setbacks dampen optimism

Apple’s latest earnings report showed a robust performance, with iPhone revenue reaching $85.27 billion and earnings per share of $2.84, surpassing the $2.67 consensus [1]. Nevertheless, investors are looking ahead to the company’s next hardware milestone. The anticipated foldable iPhone, projected to contribute less than 10% of this year’s product mix, is now facing engineering delays that could push its launch further out [1]. Prediction markets still assign a 77.5% chance of a launch before 2027, but the uncertainty has already weighed on the stock price.

At the same time, Apple is confronting a legal setback in China. On March 27, the Chinese Supreme People’s Court affirmed the validity of AI patents owned by Xiao‑I Corp, a decision that could force Apple into higher licensing costs in the Greater China market—a region that contributed $25.53 billion in the latest quarter, up 37.9% year over year [1]. The financial impact of the ruling remains unclear, but analysts note that it adds to broader regulatory risks in a key growth market.

Analyst outlook and market context

Despite the sell‑off, analyst sentiment has not turned sharply negative. UBS kept a neutral rating with a $280 price target, citing continued growth in the App Store and Services segments [1]. Bank of America maintained a Buy rating with a $320 target, pointing to upcoming product releases and AI integration as potential catalysts [1]. Overall, the average price target across analysts sits near $295, with 30 Buy, 16 Hold, and only 2 Sell recommendations [1].

Apple’s market cap of roughly $4.5 trillion underscores its scale, ranking it as the third‑largest public company worldwide [3]. The stock’s recent decline contrasts with its broader 12‑month gain of about 55%, reflecting the market’s confidence in Apple’s long‑term earnings power even as short‑term concerns emerge.